Discreet, evidence-based care for Arkansas women — HSDD, perimenopause, menopausal hormone therapy, low-dose testosterone for women, and vaginal estrogen — delivered by clinicians licensed in Arkansas.
OmniRx Health providers are licensed by the Arkansas State Medical Board to deliver telehealth services to patients across all 75 counties.
Hypoactive sexual desire disorder affects about 1 in 10 adult women. Treatable with FDA-approved Addyi or Vyleesi, low-dose testosterone, and addressing modifiable contributors like SSRIs and contraceptive choice.
Modern menopausal hormone therapy — typically transdermal estradiol with cyclic or continuous progesterone — for hot flashes, sleep disruption, libido changes, and mood symptoms.
Local vaginal estrogen, DHEA inserts (prasterone), and ospemifene for genitourinary symptoms with very low systemic absorption.
Off-label and supported by international guidelines for postmenopausal HSDD. Carefully titrated based on baseline labs, with quarterly monitoring.
Arkansas's telehealth laws support comprehensive virtual care delivery, with the Arkansas Telemedicine Act establishing clear guidelines for licensed providers.
Arkansas-licensed pharmacies in Little Rock, Fayetteville, Fort Smith, and throughout the state partner with us for prescription fulfillment and home delivery.
Visits, intake forms, and lab results are protected health information. Medication ships in plain, unmarked packaging anywhere in Arkansas. If you choose cash-pay, no insurance EOB is sent to your household.